Furthermore, we found significant differences in clinicopathological characteristics (age, gender, fibrosis Ishak score, pathologic T, and race) between HSPA1A, NR1I3, PPARGC1A, and MAT1A gene expressions and hepatocellular carcinoma patients (Tables S9–S12). Here, PPARGC1A is linked to hepatocellular carcinoma.